McMillion Capital Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$281K Hold
2,000
0.25% 66
2023
Q1
$283K Hold
2,000
0.27% 67
2022
Q4
$313K Hold
2,000
0.28% 68
2022
Q3
$245K Hold
2,000
0.23% 71
2022
Q2
$266K Hold
2,000
0.22% 73
2022
Q1
$274K Hold
2,000
0.17% 74
2021
Q4
$346K Hold
2,000
0.19% 73
2021
Q3
$291K Hold
2,000
0.17% 72
2021
Q2
$264K Hold
2,000
0.14% 70
2021
Q1
$257K Hold
2,000
0.15% 71
2020
Q4
$238K Hold
2,000
0.14% 70
2020
Q3
$229K Hold
2,000
0.17% 63
2020
Q2
$228K Hold
2,000
0.15% 62
2020
Q1
$161K Hold
2,000
0.11% 60
2019
Q4
$214K Hold
2,000
0.1% 66
2019
Q3
$214K Hold
2,000
0.11% 65
2019
Q2
$204K Buy
+2,000
New +$192K 0.11% 66
2018
Q4
Sell
-2,000
Closed -$216K 63
2018
Q3
$216K Sell
2,000
-6
-0.3% -$658 0.12% 66
2018
Q2
$221K Buy
2,006
+6
+0.3% +$625 0.13% 69
2018
Q1
$201K Buy
+2,000
New +$205K 0.12% 67
2017
Q3
Sell
-2,000
Closed -$222K 65
2017
Q2
$222K Buy
+2,000
New +$211K 0.15% 60

Other funds holding DGX

McMillion Capital Management's DGX Position: Q2 2023 in Review

McMillion Capital Management held its Quest Diagnostics (DGX) position steady in Q2 2023 at 2,000 shares worth $281K. The position accounts for 0.25% of the portfolio, ranked #66.

McMillion Capital Management first reported a position in DGX in Q2 2017 and has held it in 21 quarters since. The position peaked at $346K in Q4 2021. 820 funds tracked by Wall St. Rank hold DGX as of Q2 2023.

  • McMillion Capital Management held 2,000 shares of Quest Diagnostics worth $281K as of Q2 2023.
  • McMillion Capital Management left its Quest Diagnostics share count unchanged in Q2 2023.
  • Quest Diagnostics made up 0.25% of McMillion Capital Management's portfolio in Q2 2023, its #66 holding.
  • McMillion Capital Management first reported a position in Quest Diagnostics in Q2 2017 and has held it in 21 quarters since.
  • McMillion Capital Management's Quest Diagnostics position peaked at $346K in Q4 2021.
  • 820 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.

Based on McMillion Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.